The institutional cluster is mixed but net bearish in dollar terms, with large holders trimming while smaller funds add. The Q2 earnings showed strong top-line growth but expanding losses, and the Alzheimer's agitation launch costs are weighing on profitability. With no insider buying to corroborate the bullish side and poor historical model performance on AXSM (avg -8.5% alpha at T+20), traders should be cautious. Monitor next quarter for evidence that the Alzheimer's launch spend is translating into revenue acceleration.
Executive Summary
Q2 2026 13F cluster for Axsome Therapeutics shows a mixed institutional picture: 9 smaller buyers added $24.4M in new positions, while 8 larger sellers trimmed $57.4M, led by Assenagon Asset Management ($35.1M trim) and Nuveen ($10.2M trim). The buying is concentrated among smaller asset managers and state pension funds, while the selling is dominated by larger institutional holders. This divergence, combined with the company's Q2 earnings report 2 days ago showing strong revenue growth (+46% YoY to $218.4M) but widening losses (-$51.3M net loss), suggests institutions are split on the risk/reward of the Alzheimer's agitation launch ramp versus escalating SG&A costs.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$18.5M
▲ Buyers (9)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Russell Investments Group | ADD | +69.6% | $14.8M | $8.8M |
| State Board Of Administration Of Florida | DOUBLED | +245.2% | $7.7M | $6.1M |
| Fifth Third Bancorp | ADD | +53.2% | $6.1M | $3.3M |
| Police & Firemen's Retirement System Of New | ADD | +74.5% | $4.8M | $2.9M |
| Imc-Chicago | ADD | +29.8% | $2.5M | $1.2M |
| Mml Investors Services | DOUBLED | +146.8% | $1.3M | $919.0K |
| Polen Capital Management | DOUBLED | +111.2% | $1.1M | $736.0K |
| Commonwealth Equity Services | ADD | +47.1% | $597.0K | $317.0K |
| Farther Finance Advisors | ADD | +76.4% | $126.0K | $76.0K |
▼ Sellers (8)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | TRIM | -47.5% | $146.4M | -$35.1M |
| Nuveen | TRIM | -43.4% | $56.7M | -$10.2M |
| Aberdeen Group | TRIM | -47.7% | $25.3M | -$6.2M |
| Walleye Capital | NEAR_EXIT | -95.1% | $5.9M | -$5.5M |
| Strs Ohio | NEAR_EXIT | -91.3% | $1.8M | -$1.6M |
| M&G | TRIM | -35.4% | $15.4M | -$987.2K |
| Citigroup | TRIM | -26.3% | $31.4M | $2.1M |
| Atria Investments | TRIM | -30.1% | $232.0K | $3.0K |
Key Facts
- 9 buyers added $24.4M in new positions; 8 sellers trimmed $57.4M
- Largest seller: Assenagon Asset Management trimmed 47.5% of its position, reducing by $35.1M
- Largest buyer: Russell Investments Group added $8.8M (+69.6% shares)
- State Board of Administration of Florida doubled its position (+245.2%, +$6.1M)
- Q2 2026 revenue grew 46% YoY to $218.4M, but net loss widened to $51.3M
- No insider open-market buying corroborates the institutional cluster
- Historical model performance on AXSM is poor: avg T+20 alpha of -8.51% with 22% win rate
Financial Impact
Net institutional selling of ~$33.0M ($57.4M sold vs $24.4M bought). The largest single move was Assenagon's $35.1M trim, representing 0.3% of AXSM's $11.4B market cap.
Risk Factors
- Alzheimer's agitation launch costs may continue to pressure margins and delay profitability
- Larger institutional sellers (Assenagon, Nuveen, Aberdeen) may continue reducing positions
- Historical model performance on AXSM shows poor predictive power with negative average alpha
- No insider buying to confirm the bullish thesis from smaller buyers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-AXSM-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Institutional Cluster | $214.66 $211.12 | ▼ −1.65% | ▲ +0.25% | — |
Aug 10, 2026 7w ago | 8-K | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | — |
Aug 10, 2026 7w ago | Press Release | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | — |
Jul 15, 2026 11w ago | Press Release | $237.53 $214.66 | ▼ −9.63% | ▼ −11.97% | — |
Jul 9, 2026 12w ago | Court Ruling | $248.95 $210.13 | ▼ −15.59% | ▼ −17.84% | — |
Jul 7, 2026 12w ago | Press Release | $249.76 $211.04 | ▼ −15.50% | ▼ −16.84% | — |
Jul 1, 2026 13w ago | 144 | $244.31 $234.64 | ▼ −3.96% | ▼ −3.54% | — |
Jun 15, 2026 15w ago | Press Release | $253.40 $228.28 | ▼ −9.91% | ▼ −9.16% | — |
Jun 12, 2026 16w ago | Insider Cluster | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | — |
Jun 11, 2026 16w ago | 144 | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access